Axcella Health (NASDAQ:AXLA) Lowered to "Hold" at Zacks Inve

Zacks Investment Research cut shares of Axcella Health (NASDAQ:AXLA – Get Rating) from a buy rating to a hold rating in a research note released on Tuesday morning, Zacks.com reports. According to Zacks, “Axcella Health Inc. is a biotechnology company. It is engaged in the research and development of novel multifactorial interventions to support health […]

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Massachusetts , United States , William Hinshaw , Geode Capital Management , Analyst Recommendations For Axcella Health , Zacks Investment Research , Renaissance Technologies , Axcella Health Company Profile Get Rating , Marshall Wace , Axcella Health Inc , Pinnacle Private Wealth , Axcella Health , Millennium Management , Get Rating , Capital Management , Health Company Profile , Nasdaq Axla , Taxla , Medical , Downgrade ,